These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16916538)

  • 1. Methylphenidate and cocaine: a placebo-controlled drug interaction study.
    Winhusen T; Somoza E; Singal BM; Harrer J; Apparaju S; Mezinskis J; Desai P; Elkashef A; Chiang CN; Horn P
    Pharmacol Biochem Behav; 2006 Sep; 85(1):29-38. PubMed ID: 16916538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metyrapone and cocaine: a double-blind, placebo-controlled drug interaction study.
    Winhusen T; Somoza E; Harrer JM; Moore E; Ussery T; Kropp F; Singal B; Elkashef A; Mojsiak J
    Pharmacol Biochem Behav; 2005 Apr; 80(4):631-8. PubMed ID: 15820533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.
    Collins SL; Levin FR; Foltin RW; Kleber HD; Evans SM
    Drug Alcohol Depend; 2006 Apr; 82(2):158-67. PubMed ID: 16213109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR; Evans SM; Brooks DJ; Garawi F
    Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
    Hammerness P; Wilens T; Mick E; Spencer T; Doyle R; McCreary M; Becker J; Biederman J
    J Pediatr; 2009 Jul; 155(1):84-9, 89.e1. PubMed ID: 19394037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
    Levin FR; Evans SM; McDowell DM; Brooks DJ; Nunes E
    J Addict Dis; 2002; 21(2):1-16. PubMed ID: 11916368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
    Spencer TJ; Adler LA; McGough JJ; Muniz R; Jiang H; Pestreich L;
    Biol Psychiatry; 2007 Jun; 61(12):1380-7. PubMed ID: 17137560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
    Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
    Coghill DR; Rhodes SM; Matthews K
    Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Medori R; Ramos-Quiroga JA; Casas M; Kooij JJ; Niemelä A; Trott GE; Lee E; Buitelaar JK
    Biol Psychiatry; 2008 May; 63(10):981-9. PubMed ID: 18206857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX; Ma HW; Wan B; Dai XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients.
    Vogel M; Bucher P; Strasser J; Liechti ME; Krähenbühl S; Dürsteler KM
    J Psychoactive Drugs; 2016; 48(2):93-100. PubMed ID: 26940988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
    Adler LA; Spencer T; McGough JJ; Jiang H; Muniz R
    J Atten Disord; 2009 Mar; 12(5):449-59. PubMed ID: 19218542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.